Literature DB >> 20441793

Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease.

Miguel Agustin Contreras1, William Louis Ries, Srinivasan Shanmugarajan, Gonzalo Arboleda, Inderjit Singh, Avtar Kaur Singh.   

Abstract

Krabbe disease is an inherited lysosomal disorder in which galactosylsphingosine (psychosine) accumulates mainly in the central nervous system. To gain insight into the possible mechanism(s) that may be participating in the inhibition of the postnatal somatic growth described in the animal model of this disease (twitcher mouse, twi), we studied their femora. This study reports that twi femora are smaller than of those of wild type (wt), and present with abnormality of marrow cellularity, bone deposition (osteoblastic function), and osteoclastic activity. Furthermore, lipidomic analysis indicates altered sphingolipid homeostasis, but without significant changes in the levels of sphingolipid-derived intermediates of cell death (ceramide) or the levels of the osteoclast-osteoblast coupling factor (sphingosine-1-phosphate). However, there was significant accumulation of psychosine in the femora of adult twi animals as compared to wt, without induction of tumor necrosis factor-alpha or interleukin-6. Analysis of insulin-like growth factor-1 (IGF-1) plasma levels, a liver secreted hormone known to play a role in bone growth, indicated a drastic reduction in twi animals when compared to wt. To identify the cause of the decrease, we examined the IGF-1 mRNA expression and protein levels in the liver. The results indicated a significant reduction of IGF-1 mRNA as well as protein levels in the liver from twi as compared to wt littermates. Our data suggest that a combination of endogenous (psychosine) and endocrine (IGF-1) factors play a role in the inhibition of postnatal bone growth in twi mice; and further suggest that derangements of liver function may be contributing, at least in part, to this alteration. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20441793      PMCID: PMC2950787          DOI: 10.1016/j.bbadis.2010.04.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  68 in total

1.  Inhibition of cytochrome c oxidase by psychosine (galactosylsphingosine).

Authors:  H Igisu; M Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

2.  Expression of major histocompatibility complex class I antigens in the demyelinating twitcher CNS and PNS.

Authors:  M Taniike; J R Marcus; B Popko; K Suzuki
Journal:  J Neurosci Res       Date:  1997-03-01       Impact factor: 4.164

3.  An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy.

Authors:  M Taniike; I Mohri; N Eguchi; D Irikura; Y Urade; S Okada; K Suzuki
Journal:  J Neuropathol Exp Neurol       Date:  1999-06       Impact factor: 3.685

4.  Regulation of insulin-like growth factor I gene expression by growth hormone.

Authors:  L S Mathews; G Norstedt; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin.

Authors:  N L Schlechter; S M Russell; E M Spencer; C S Nicoll
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Cerebrosides and psychosine disrupt mitochondrial functions.

Authors:  P Strasberg
Journal:  Biochem Cell Biol       Date:  1986-05       Impact factor: 3.626

7.  Growth hormone regulates the abundance of insulin-like growth factor I RNA in adult rat liver.

Authors:  C T Roberts; A L Brown; D E Graham; S Seelig; S Berry; K H Gabbay; M M Rechler
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

8.  Globoid cell leukodystrophy is a generalized galactosylsphingosine (psychosine) storage disease.

Authors:  T Kobayashi; H Shinoda; I Goto; T Yamanaka; Y Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

9.  Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density.

Authors:  C J Rosen; E S Kurland; D Vereault; R A Adler; P J Rackoff; W Y Craig; S Witte; J Rogers; J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1998-07       Impact factor: 5.958

Review 10.  Sphingosine-1-phosphate in cell growth and cell death.

Authors:  S Spiegel; O Cuvillier; L C Edsall; T Kohama; R Menzeleev; Z Olah; A Olivera; G Pirianov; D M Thomas; Z Tu; J R Van Brocklyn; F Wang
Journal:  Ann N Y Acad Sci       Date:  1998-06-19       Impact factor: 5.691

View more
  7 in total

1.  Psychosine inhibits osteoclastogenesis and bone resorption via G protein-coupled receptor 65.

Authors:  S H Ahn; S-Y Lee; J-E Baek; S-Y Lee; S-Y Park; Y-S Lee; H Kim; B-J Kim; S H Lee; J-M Koh
Journal:  J Endocrinol Invest       Date:  2015-04-05       Impact factor: 4.256

2.  Effect of vitamin D3 intake on the onset of disease in a murine model of human Krabbe disease.

Authors:  Manjeet K Paintlia; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2014-09-19       Impact factor: 4.164

3.  Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.

Authors:  Mirella Belleri; Roberto Ronca; Daniela Coltrini; Beatrice Nico; Domenico Ribatti; Pietro L Poliani; Arianna Giacomini; Patrizia Alessi; Sergio Marchesini; Marta B Santos; Ernesto R Bongarzone; Marco Presta
Journal:  Brain       Date:  2013-09       Impact factor: 13.501

4.  Effect of glycosphingolipids on osteoclastogenesis and osteolytic bone diseases.

Authors:  Adel Ersek; Anastasios Karadimitris; Nicole J Horwood
Journal:  Front Endocrinol (Lausanne)       Date:  2012-08-23       Impact factor: 5.555

Review 5.  Sphingosine 1-Phosphate Receptors and Metabolic Enzymes as Druggable Targets for Brain Diseases.

Authors:  Sara Grassi; Laura Mauri; Simona Prioni; Livia Cabitta; Sandro Sonnino; Alessandro Prinetti; Paola Giussani
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

6.  Characterization of adipose-derived stromal/stem cells from the Twitcher mouse model of Krabbe disease.

Authors:  Xiujuan Zhang; Julie A Semon; Shijia Zhang; Amy L Strong; Brittni A Scruggs; Jeffrey M Gimble; Bruce A Bunnell
Journal:  BMC Cell Biol       Date:  2013-04-16       Impact factor: 4.241

7.  β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease.

Authors:  Mirella Belleri; Daniela Coltrini; Marco Righi; Cosetta Ravelli; Sara Taranto; Paola Chiodelli; Stefania Mitola; Marco Presta; Arianna Giacomini
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.